Terms: = Lung cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Diagnosis
248 results:
1. HBB as a Novel Biomarker for the diagnosis and Monitoring of lung cancer Regulates Cell Proliferation via ERK1/2 Pathway.
Xu X; Cai H; Peng J; Liu H; Chu F
Technol Cancer Res Treat; 2024; 23():15330338241249032. PubMed ID: 38679728
[No Abstract] [Full Text] [Related]
2. Humoral immune response to tumor-associated antigen Ubiquilin 1 (UBQLN1) and its tumor-promoting potential in lung cancer.
Wang Y; Ouyang S; Liu M; Si Q; Zhang X; Zhang X; Li J; Wang P; Ye H; Shi J; Song C; Wang K; Dai L
BMC Cancer; 2024 Mar; 24(1):283. PubMed ID: 38431566
[TBL] [Abstract] [Full Text] [Related]
3. Rapid automated extracellular vesicle isolation and miRNA preparation on a cost-effective digital microfluidic platform.
Tong Z; Yang D; Shen C; Li C; Xu X; Li Q; Wu Z; Ma H; Chen F; Mao H
Anal Chim Acta; 2024 Apr; 1296():342337. PubMed ID: 38401929
[TBL] [Abstract] [Full Text] [Related]
4. Exosomal long non-coding RNA MALAT1: a candidate of liquid biopsy in monitoring of Wilms' tumor.
Sharma D; Singh A; Wilson C; Swaroop P; Kumar S; Yadav DK; Jain V; Agarwala S; Husain M; Sharawat SK
Pediatr Surg Int; 2024 Feb; 40(1):57. PubMed ID: 38353772
[TBL] [Abstract] [Full Text] [Related]
5. sPD-L1 and sPD-L2 in plasma of patients with lung cancer and their clinical significance.
Han S; Zhang Y; Yuan J; Wu Y; Zhou Y; Zhou Y; Li X; Zhou S
Cytokine; 2024 Apr; 176():156532. PubMed ID: 38330638
[TBL] [Abstract] [Full Text] [Related]
6. Single-Cell Liquid Biopsy of lung cancer: Ultra-Simplified Efficient Enrichment of Circulating Tumor Cells and Hand-Held Fluorometer Portable Testing.
He Y; Zhan Z; Yan L; Wu C; Wang Y; Shen C; Huang K; Wei Z; Lin F; Ying B; Li W; Chen P
ACS Nano; 2024 Feb; 18(6):5017-5028. PubMed ID: 38305181
[TBL] [Abstract] [Full Text] [Related]
7. Acute mast cell leukemia without kit D816V mutation and lack of CD2 and CD25-a case report of rare entity.
Zaremba-Pataj E; Patkowska E; Krzywdzińska A; Szumera-Ciećkiewicz A; Chlebowska-Tuz J
J Hematop; 2023 Mar; 16(1):39-47. PubMed ID: 38175371
[TBL] [Abstract] [Full Text] [Related]
8. A comparative study on ctDNA and tumor DNA mutations in lung cancer and benign cases with a high number of CTCs and CTECs.
Xie J; Hu B; Gong Y; He S; Lin J; Huang Q; Cheng J
J Transl Med; 2023 Dec; 21(1):873. PubMed ID: 38041139
[TBL] [Abstract] [Full Text] [Related]
9. Fusion expression, purification, and characterization of cytokeratin 19 fragments in E. coli for enhanced stability in diagnostic applications.
Liu Y; Zhu P; Ji C; Dong L; Yi W
Protein Expr Purif; 2024 Mar; 215():106410. PubMed ID: 38040273
[TBL] [Abstract] [Full Text] [Related]
10. Comprehensive study of clinicopathological and immune cell infiltration and lactate dehydrogenase expression in patients with thymic epithelial tumours.
Ying J; Huang Y; Ye X; Zhang Y; Yao Q; Wang J; Yang X; Yu C; Guo Y; Zhang X; Lv Q; Wang C; Mao W; Zhao A
Int Immunopharmacol; 2024 Jan; 126():111205. PubMed ID: 38029550
[TBL] [Abstract] [Full Text] [Related]
11. [miR-218-5p Targeting TPX2 Regulates p53 Pathway and Inhibits Malignant Progression of lung Adenocarcinoma].
Xu J
Zhongguo Fei Ai Za Zhi; 2023 Oct; 26(10):721-731. PubMed ID: 37989335
[TBL] [Abstract] [Full Text] [Related]
12. Multi-gene Liquid Biopsy to Detect Resistance to First-line Osimertinib in Patients With
Ito S; Tsurumi K; Shindo N; Soma S; Yamaguchi K; Tamai K; Mochizuki M; Fujimori H; Morita M; Watanabe K; Suzuki A; Fukuhara T; Yasuda J
Anticancer Res; 2023 Nov; 43(11):5031-5040. PubMed ID: 37909987
[TBL] [Abstract] [Full Text] [Related]
13. Comparison of Confirmed Cytology Smears and Cell Blocks for Epidermal Growth Factor Receptor Mutation Testing in Non-Small Cell lung cancer.
Liu CH; Chang SJ; Tsai MJ; Yang SF
Appl Immunohistochem Mol Morphol; 2023 Nov-Dec 01; 31(10):701-706. PubMed ID: 37807651
[TBL] [Abstract] [Full Text] [Related]
14. Bronchial oncocytic carcinoma in an adult: a case report and literature review.
Shen YF; Wang CL; Chu ZG; Cao YD; Luo Y; Zhang YL; Cao YJ
BMC Pulm Med; 2023 Oct; 23(1):375. PubMed ID: 37803309
[TBL] [Abstract] [Full Text] [Related]
15. Clinical profile of anti-NXP-2 antibody-positive inflammatory myositis and outcome in an Indian population.
Manwatkar A; Padiyar S; Nair A; Jha A; Kumar S; Yadav B; Prakash JAJ; Das JK; Mathew J
Clin Rheumatol; 2023 Dec; 42(12):3289-3297. PubMed ID: 37801141
[TBL] [Abstract] [Full Text] [Related]
16. TET2 inhibits the proliferation and metastasis of lung adenocarcinoma cells via activation of the cGAS-STING signalling pathway.
Cheng G; Wu J; Ji M; Hu W; Wu C; Jiang J
BMC Cancer; 2023 Sep; 23(1):825. PubMed ID: 37667220
[TBL] [Abstract] [Full Text] [Related]
17. Circulating exosomal microRNA-4497 as a potential biomarker for metastasis and prognosis in non-small-cell lung cancer.
Zheng B; Peng M; Gong J; Li C; Cheng H; Li Y; Tang Y
Exp Biol Med (Maywood); 2023 Aug; 248(16):1403-1413. PubMed ID: 37551102
[TBL] [Abstract] [Full Text] [Related]
18. Highly Sensitive Enrichment of Low-Frequency Variants by Hairpin Competition Amplification.
Liu Z; Zhang R; Jiang X; Ji L; Sun P; Ji Y; Zhang Y; Ding Y; Li K; Pu Z; Zhou F; Zou J
Anal Chem; 2023 Aug; 95(32):12015-12023. PubMed ID: 37527514
[TBL] [Abstract] [Full Text] [Related]
19. GPD1L inhibits renal cell carcinoma progression by regulating PINK1/Parkin-mediated mitophagy.
Liu T; Zhu H; Ge M; Pan Z; Zeng Y; Leng Y; Yang K; Cheng F
J Cell Mol Med; 2023 Aug; 27(16):2328-2339. PubMed ID: 37382962
[TBL] [Abstract] [Full Text] [Related]
20. Quantitative analysis of a novel DNA hypermethylation panel using bronchial specimen for lung cancer diagnosis.
Dou M; Li D; Zhu M; Guo W; Miao C; Li M; Xue Y; He R; Jiang N; Ge D; Hu Q; Shao Y; Hou Y; Wang X; Huang X; Liu T; Wang Q; Wang Y; Sun J; Wang W; Song Y; Hu J; Huang Q
Int J Cancer; 2023 Sep; 153(5):1096-1107. PubMed ID: 37232006
[TBL] [Abstract] [Full Text] [Related]
[Next]
